Tailoring lipid nanoparticle dimensions through manufacturing processes
McMillan, Caitlin and Druschitz, Amy and Rumbelow, Stephen and Borah, Ankita and Binici, Burcu and Rattray, Zahra and Perrie, Yvonne (2024) Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC Pharmaceutics, 1 (4). pp. 841-853. ISSN 2976-8713 (https://doi.org/10.1039/D4PM00128A)
Preview |
Text.
Filename: McMillan-etal-2024-Tailoring-lipid-nanoparticle-dimensions-through-manufacturing-processes.pdf
Final Published Version License: Download (3MB)| Preview |
Abstract
Lipid nanoparticles (LNPs), most commonly recognised for their role in COVID-19 mRNA vaccines, are important delivery vehicles for nucleic acid (mRNA, siRNA) therapies. The physicochemical attributes, such as size, nucleic acid encapsulation and electric charge, may have a significant impact on the efficacy of these medicines. In this study, adjustments to aqueous to lipid phase ratios were assessed for their impact on LNP size and other critical quality attributes (CQAs). It was observed that minor adjustments of aqueous-to-organic lipid phase ratios can be used to precisely control the size of ALC-0315-formulated LNPs. This was then used to evaluate the impact of phase ratio and corresponding size ranges on the in vitro and in vivo expression of these LNPs. In HEK293 cells, larger LNPs led to higher expression of the mRNA cargo within the LNPs, with a linear correlation between size and expression. In THP-1 cells this preference for larger LNPs was observed up to 120 d.nm after which there was a fall in expression. In BALB/c mice, however, LNPs at the lowest phase ratio tested, >120 d.nm, showed reduced expression compared to those of range 60–120 d.nm, within which there was no significant difference between sizes. These results suggest a robustness of LNP expression up to 120 d.nm, larger than those
ORCID iDs
McMillan, Caitlin, Druschitz, Amy, Rumbelow, Stephen, Borah, Ankita, Binici, Burcu, Rattray, Zahra ORCID: https://orcid.org/0000-0002-8371-8549 and Perrie, Yvonne;-
-
Item type: Article ID code: 90628 Dates: DateEvent23 September 2024Published23 September 2024Published Online29 August 2024AcceptedSubjects: Medicine > Pharmacy and materia medica > Pharmaceutical chemistry Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 23 Sep 2024 09:03 Last modified: 21 Nov 2024 01:26 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/90628